Symbol="RGNX"
AssetType="Common Stock"
Name="Regenxbio Inc"
Description="REGENXBIO Inc., a clinical-stage biotechnology company, offers candidate gene therapy products to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies intended to affect disease. The company is headquartered in Rockville, Maryland."
CIK="1590877"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="9600 BLACKWELL ROAD, SUITE 210, ROCKVILLE, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="774785000"
EBITDA="-250092992"
PERatio="None"
PEGRatio="0.26"
BookValue="9.3"
DividendPerShare="0"
DividendYield="0"
EPS="-6.05"
RevenuePerShareTTM="2.235"
ProfitMargin="-2.827"
OperatingMarginTTM="-2.747"
ReturnOnAssetsTTM="-0.203"
ReturnOnEquityTTM="-0.529"
RevenueTTM="96972000"
GrossProfitTTM="-184274000"
DilutedEPSTTM="-6.05"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.388"
AnalystTargetPrice="41.36"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.063"
PriceToBookRatio="1.825"
EVToRevenue="1.531"
EVToEBITDA="5.94"
Beta="1.089"
num_52WeekHigh="33.9"
num_52WeekLow="17.02"
num_50DayMovingAverage="18.99"
num_200DayMovingAverage="20.76"
SharesOutstanding="43466200"
DividendDate="None"
ExDividendDate="None"
symbol="RGNX"
open="18.10"
high="18.23"
low="17.60"
price="17.69"
volume="269821.00"
latest_trading_day="2023-08-17"
previous_close="18.00"
change="-0.31"
change_percent="-1.7222%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="396526"
Change_recent_avg="-0.01"
Delta_recent_avg="0.97"
Variance_recent_avg="0.48"
Change_ratio_recent_avg="-0.11"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="175"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0001.jpeg"
image_negative_thumbnail_id_2="102"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0074.jpeg"
image_neutral_thumbnail_id_1="582"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_neutral_thumbnail_id_2="525"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_positive_thumbnail_id_1="953"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0115.jpeg"
image_positive_thumbnail_id_2="667"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0041.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
